KEMAL NAS
(Dicle Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Diyarbakır, Türkiye)
REMZİ ÇEVİK
(Dicle Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Diyarbakır, Türkiye)
Mehtap BOZKURT
(Dicle Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Diyarbakır, Türkiye)
Ali GÜR
(Dicle Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Diyarbakır, Türkiye)
Ayşegül Jale SARAÇ
(Dicle Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Diyarbakır, Türkiye)
Yıl: 2011Cilt: 26Sayı: 1ISSN: 1309-0291Sayfa Aralığı: 29 - 37İngilizce

118 1
Relationship Between Clinical Findings, Quality of Life and Functional Disability Related to Disease Activity in Patients with Ankylosing Spondylitis
Amaç: Bu çalışmada ankilozan spondilitli (AS) hastalarda hastalık aktivitesiyle ilişkili fonksiyonel disabilite, yaşam kalitesi ve klinik bulgular arasındaki ilişkiler değerlendirildi.Hastalar ve yöntemler: Ankilozan spondilit tanısı konulan ve modifiye New York kriterlerine uyan 73 hasta (62 erkek, 11 kadın; ort. yaş 33.3±9.5 yıl; dağılım 17-60 yıl) çalışmaya alındı. Kadın hastaların yaş ortalaması 29.2±7.3, erkek hastaların yaş ortalaması ise 34.0±9.7 yıl idi. Hastaların demografik verileri kaydedildi. Hastalık aktivitesi, Bath ankilozan spondilit hastalık aktivitesi indeksi (BASDAI) kullanılarak değerlendirildi. Fonksiyonel disabilite, Bath ankilozan spondilit fonksiyonel indeksi (BASFI) kullanılarak değerlendirildi. Klinik durum Bath ankilozan spondilit metroloji indeksi (BASMI) ve yaşam kalitesi ise Short Form 36 (KF-36) ile değerlendirildi.Bulgular: Hastalar BASDAI puanı dörtten düşük (BASDAI <4) olan ve hafif hastalık aktivitesi gösteren hastalar (n=34) ve BASDAI skoru dört ya da daha yüksek (BASDAI >=4) olan ve orta seviyeli ila ağır hastalık aktivitesi gösteren hastalar (n=39) olarak iki gruba ayrıldı. BASFI ve BASMI skoru ağır hastalık aktivitesine sahip hastalarda daha yüksekti (p<0.05) ve total BASDAI skoru ile BASFI ve BASMI skorları arasında anlamlı ilişki bulundu (p<0.05). BASDAI puanı <4 olan hastalar BASDAI puanı >=4 olan hastalarla karşılaştırıldığında daha düşük el parmak zemin mesafesine ve daha yüksek servikal rotasyon ve modifiye Shober ölçüm değerlerine sahipti. BASDAI skoru ile fiziksel fonksiyon, fiziksel rol, vücut ağrısı ve emosyonel rolün SF-36 subskorları arasında anlamlı bir ilişki vardı (p<0.05).Sonuç: Ankilozan spondilitte hastalık aktivitesi; yaşam kalitesi, klinik bulgular, fonksiyonel disabilite ve metrolojik ölçümleri olumsuz etkilemektedir. Short form-36 ölçeğinin alt fiziksel sağlık ile ilgili alt puanları AS hastalık aktivitesi ile daha anlamlı ilişki göstermektedir.
Fen > Tıp > Romatoloji
DergiAraştırma MakalesiErişime Açık
  • Forejtová S, Mann H, Stolfa J, Vedral K, Fenclová I, Némethová D, et al. Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic. Clin Rheumatol 2008;27:1005-13.
  • Bostan EE, Borman P, Bodur H, Barça N. Functional disability and quality of life in patients with ankylosing
  • Zink A, Braun J, Listing J, Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis-results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000;27:613-22.
  • Ortiz Z, Shea B, Garcia Dieguez M, Boers M, Tugwell P, Boonen A, et al. The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials. J Rheumatol 1999;26:210-6.
  • Turan Y, Duruöz MT, Cerrahoglu L. Quality of life in patients with ankylosing spondylitis: a pilot study. Rheumatol Int 2007;27:895-9.
  • Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landewé R, Dougados M, Mielants H, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 2004;51:154-9.
  • Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 1999;38:878-82.
  • Taylor AL, Balakrishnan C, Calin A. Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum 1998;41:1119-25.
  • Ward MM. Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 2002;29:1420-5.
  • Falkenbach A, Franke A, van der Linden S. Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 2003;30:2186-92.
  • van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
  • Ariza-Ariza R, Hernández-Cruz B, Navarro-Sarabia F. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 2003;49:483-7.
  • Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694-8.
  • Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A. A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol 1995;22:1609.
  • Yanik B, Gürsel YK, Kutlay S, Ay S, Elhan AH. Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 2005;24:41-7.
  • Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005;25:280-4.
  • Calin A, Mackay K, Santos H, Brophy S. A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol 1999;26:988-92.
  • Kaya A, Ozgocmen S, Kamanli A, Aydogan R, Yildirim A, Ardicoglu O. Evaluation of a quantitative scoring of enthesitis in ankylosing spondylitis. J Clin Rheumatol 2007;13:303-6.
  • Zochling J, Braun J. Assessment of ankylosing spondylitis. Clin Exp Rheumatol 2005;23(5 Suppl 39):S133-41.
  • Ward MM. Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999;12:247-55.
  • Taylor WJ, Harrison AA. Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 2004;51:311-5.
  • Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-7.
  • Baek HJ, Shin KC, Lee YJ, Kang SW, Lee EB, Yoo CD, et al. Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology (Oxford) 2004; 43:1526-31.
  • Bodur H, Ataman S, Akbulut L, Evcik D, Kavuncu V, Kaya T, et al. Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 2008;27:1119-25.
  • Spoorenberg A, van Tubergen A, Landewé R, Dougados M, van der Linden S, Mielants H, et al. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 2005;44:789-95.
  • Maksymowych WP. Ankylosing spondylitis. Not just another pain in the back. Can Fam Physician 2004; 50:257-62.
  • Oniankitan O, Ranaivo N, Carton L, Chevalier X, Claudepierre P. Poorly and well controlled spondyloarthropathies: a comparison of 2 groups of patients. J Rheumatol 2005;32:77-9.
  • Vesovi?-Poti? V, Mustur D, Stanisavljevi? D, Ille T, Ille M. Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2009;29:879-84.
  • Uppal SS, Abraham M, Chowdhury RI, Kumari R, Pathan EM, Al Rashed A. Ankylosing spondylitis and undifferentiated spondyloarthritis in Kuwait: a comparison between Arabs and South Asians. Clin Rheumatol 2006;25:219-24.
  • Dalyan M, Güner A, Tuncer S, Bilgiç A, Arasil T. Disability in ankylosing spondylitis. Disabil Rehabil 1999;21:74-9.
  • Kaan U, Ferda O. Evaluation of clinical activity and functional impairment in smokers with ankylosing
  • Kaya T, Bal S, Gunaydin R. Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis. Rheumatol Int 2007;27:323-7.
  • Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-4.
  • Zhao LK, Liao ZT, Li CH, Li TW, Wu J, Lin Q, et al. Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population. Rheumatol Int 2007;27:605-11.
  • Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988;15:302-7.
  • Brandt J, Listing J, Haibel H, Sörensen H, Schwebig A, Rudwaleit M, et al. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis. Rheumatology (Oxford) 2005;44:342-8.
  • What quality of life? The WHOQOL Group. World Health Organization Quality of Life Assessment. World Health Forum 1996;17:354-6.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.